We still have to continue to test, test, test
Testing for COVID-19 is performed curatively for disease detection and as screening tool to prevent spread for public health and infection prevention. Testing for access is an important additional measure to provide information about asymptomatic or pre-symptomatic infection. In a recent meta-analysis 42.8% showed no symptoms with an estimated percentage of asymptomatic infections of 35.1%. False positive testing is not completely preventable but allows events such as the Eurovision Song Contest, professional football, the Olympic Games or Formula 1. Their trade-off is not purely medical but also political-economical. The choice to carry out many Dutch tests in foreign laboratories is inefficient, while at the same time the opportunity to strengthen regional innovation, training and infrastructure is missed. Cooperation between municipal health departments and regional laboratories and extra service from regional laboratories (such as fast variant PCR) are frustrated this way. We hope this situation will improve rapidly.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
---|---|
Enthalten in: |
Nederlands tijdschrift voor geneeskunde - 165(2021) vom: 11. Okt. |
Sprache: |
Niederländisch |
---|
Weiterer Titel: |
We moeten nu nog blijven testen, testen, testen |
---|
Beteiligte Personen: |
Mulder, Bert [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 06.12.2021 Date Revised 14.12.2021 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM333915070 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333915070 | ||
003 | DE-627 | ||
005 | 20231225222630.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||dut c | ||
028 | 5 | 2 | |a pubmed24n1113.xml |
035 | |a (DE-627)NLM333915070 | ||
035 | |a (NLM)34854653 | ||
035 | |a (PII)D6450 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dut | ||
100 | 1 | |a Mulder, Bert |e verfasserin |4 aut | |
245 | 1 | 0 | |a We still have to continue to test, test, test |
246 | 3 | 3 | |a We moeten nu nog blijven testen, testen, testen |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2021 | ||
500 | |a Date Revised 14.12.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Testing for COVID-19 is performed curatively for disease detection and as screening tool to prevent spread for public health and infection prevention. Testing for access is an important additional measure to provide information about asymptomatic or pre-symptomatic infection. In a recent meta-analysis 42.8% showed no symptoms with an estimated percentage of asymptomatic infections of 35.1%. False positive testing is not completely preventable but allows events such as the Eurovision Song Contest, professional football, the Olympic Games or Formula 1. Their trade-off is not purely medical but also political-economical. The choice to carry out many Dutch tests in foreign laboratories is inefficient, while at the same time the opportunity to strengthen regional innovation, training and infrastructure is missed. Cooperation between municipal health departments and regional laboratories and extra service from regional laboratories (such as fast variant PCR) are frustrated this way. We hope this situation will improve rapidly | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Mooij, Ginny |e verfasserin |4 aut | |
700 | 1 | |a van Zelst, Marino |e verfasserin |4 aut | |
700 | 1 | |a Friedrich, Alexander W |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nederlands tijdschrift voor geneeskunde |d 1946 |g 165(2021) vom: 11. Okt. |w (DE-627)NLM000034231 |x 1876-8784 |7 nnns |
773 | 1 | 8 | |g volume:165 |g year:2021 |g day:11 |g month:10 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 165 |j 2021 |b 11 |c 10 |